Canterbury DHB
The prognosis of ARL has improved with developments of infusional regimens, the use of rituximab and transplantation in relapsed disease. Important differences remain in this group of patients. Special attention to prophylaxis of infection is required. See Dunleavy, K.et al. (2012). "How I treat HIV-associated lymphoma." Blood 119: 3245-55.
Topic Code: 9649